United States National Library of Medicine National Institutes of Health

2008AB MedDRA Source Information


Attribute Name Description Count (MRSAT.RRF)
SMQ_TERM_ADDVERSION Standardised MedDRA Query (SMQ) Addition Version. Version of MedDRA in which term was added to the SMQ. 90438
SMQ_TERM_CAT Standardised MedDRA Query (SMQ) Term Category. A single alphabetical letter indicating the category of the term for application of the SMQ algorithm. If the SMQ does not use algorithms, then all Term_category values are assigned "A." For a child SMQ, this field is assigned "S." 90438
SMQ_TERM_LMVERSION Standardised MedDRA Query (SMQ) Last Modified Version. Version of MedDRA in which term was last modified in the SMQ. 90438
SMQ_TERM_SCOPE Standardised MedDRA Query (SMQ) Term Scope. Defines the MedDRA term as a member of the broad scope (1), narrow scope (2) of the SMQ search, or a child SMQ (0) (zero). 90438
SMQ_TERM_STATUS Standardised MedDRA Query (SMQ) Term Status. Identifies a term as active ("A") or inactive ("I") within this SMQ. 90438
SMQ_TERM_WEIGHT Standardised MedDRA Query (SMQ) Term Weight. Used for some SMQ algorithms; "0" is used as default. 90438
MXR MedDRA cross reference to COSTART, HARTS, ICD9, ICD-9-CM, J-ART or WHOART 41689
SMQ_TERM_LEVEL Standardised MedDRA Query (SMQ) Term Level. The MedDRA hierarchy level of a term (4=PT, 5=LLT) or 0 (zero) for a child SMQ. 33118
MPS MedDRA primary SOC (PTs may have multiple treepositions, but each has a primary soc) 18075
SMQ_ALGO Standardised MedDRA Query (SMQ) Algorithm. Boolean expression of algorithm for the SMQ. "N" if the SMQ does not utilize an algorithm. 142
SMQ_LEVEL Standardised MedDRA Query (SMQ) Level. Value between 1 and 5 identifying the level of the SMQ within the hierarchy of SMQs; 1 is the most general, 5 is the most narrow. 142
SMQ_STATUS Standardised MedDRA Query (SMQ) Status. "A" = active; "I" = inactive. 142
SMQ_SOURCE Standardised MedDRA Query (SMQ) Source. Source for the development of the SMQ, e.g. medical references. 107
SOS Scope Statement 69
MISO MedDRA Serial Code International SOC Sort Order Digit (01-26) 26
FROMRSAB Root source abbreviation for the "from" identifiers of a map set 2
FROMVSAB Versioned source abbreviation for the "from" identifiers of a map set 2
MAPSETRSAB Root source abbreviation for a map set 2
MAPSETTYPE Indicates the nature of a map set. Its value is map set specific. It can be used to indicate the inclusion of one to one, one to many and choices of maps. 2
MAPSETVERSION Version of the map set 2
MAPSETVSAB Versioned source abbreviation for a map set 2
MTH_MAPFROMCOMPLEXITY Indicates the complexity of "from" expressions used in a map set 2
MTH_MAPFROMEXHAUSTIVE Indicates whether or not the "from" source of a map set is completely mapped 2
MTH_MAPSETCOMPLEXITY Indicates the overall complexity of a map set 2
MTH_MAPTOCOMPLEXITY Indicates the complexity of "to" expressions in a map set 2
MTH_MAPTOEXHAUSTIVE Indicates whether or not the "to" source is completely mapped 2
TORSAB Root source abbreviation for the "to" identifiers of a map set 2
TOVSAB Versioned source abbreviation for the "to" identifiers of a map set 2

  • Each attribute in each source is assigned an Attribute Name (ATN) based on source documentation or NLMs understanding of the source.
  • Samples below are taken from MRSAT.RRF, although not every field is shown. Associated terms (str) from MRCONSO.RRF are also shown for clarity.
  • Sample data highlight examples of ATNs and Attribute Values (ATV) in MRSAT.RRF.
  • ATN abbreviations are contained in MRSAT, i.e., DID.
  • The corresponding ATVs, i.e., Descriptor Identifier, are listed in Appendix B.2 at http://www.nlm.nih.gov/research/umls/metab2.html#sb2_0.
  • See Section 2.7.1.3.5 in UMLS Documentation Section 2, Metathesaurusfor more information on MRSAT.RRF.

SMQ_TERM_ADDVERSION  (return to top)
cui metaui stype atn atv str
C1869007 R92105150 RUI SMQ_TERM_ADDVERSION 7.1 Rhabdomyolysis/myopathy (SMQ)
C0029791 R92083506 RUI SMQ_TERM_ADDVERSION 8.0 Other specified disorders resulting from impaired renal function
C1869008 R92105448 RUI SMQ_TERM_ADDVERSION 8.0 Acute renal failure (SMQ)
C1997821 R92104629 RUI SMQ_TERM_ADDVERSION 11.0 Automated peritoneal dialysis
C0018801 R92064725 RUI SMQ_TERM_ADDVERSION 10.0 Cardiac insufficiency
C1869013 R92106170 RUI SMQ_TERM_ADDVERSION 8.0 Cholestasis and jaundice of hepatic origin (SMQ)
C0235605 R92086486 RUI SMQ_TERM_ADDVERSION 8.0 Prothrombin consumption increased
C1963900 R92104339 RUI SMQ_TERM_ADDVERSION 10.1 Pseudomembranous stomatitis
C0858530 R92073470 RUI SMQ_TERM_ADDVERSION 8.1 Heart pressure sensation of
SMQ_TERM_CAT  (return to top)
cui metaui stype atn atv str
C0853068 R92072775 RUI SMQ_TERM_CAT A Glomerular filtration rate low
C1869007 R92105110 RUI SMQ_TERM_CAT A Rhabdomyolysis/myopathy (SMQ)
C0031140 R92102686 RUI SMQ_TERM_CAT A Continuous ambulatory peritoneal dialysis
C1869091 R92105596 RUI SMQ_TERM_CAT A Cardiac failure (SMQ)
C0235525 R92080583 RUI SMQ_TERM_CAT A Myocardial decompensation
C1869014 R92106226 RUI SMQ_TERM_CAT A Hepatitis, non-infectious (SMQ)
C0580415 R92095490 RUI SMQ_TERM_CAT A Thrombin time abnormal
C1869023 R92107145 RUI SMQ_TERM_CAT A Haemolytic disorders (SMQ)
C0856144 R92100886 RUI SMQ_TERM_CAT A Hemolysis aggravated
SMQ_TERM_LMVERSION  (return to top)
cui metaui stype atn atv str
C1869019 R92106787 RUI SMQ_TERM_LMVERSION 8.0 Possible liver-related coagulation and bleeding disturbances (SMQ)
C1869038 R92107858 RUI SMQ_TERM_LMVERSION 8.1 Anaphylactic reaction (SMQ)
C1869038 R92108193 RUI SMQ_TERM_LMVERSION 9.0 Anaphylactic reaction (SMQ)
C1869026 R92108717 RUI SMQ_TERM_LMVERSION 8.1 Agranulocytosis (SMQ)
C0522044 R92094987 RUI SMQ_TERM_LMVERSION 8.1 Edema thigh
C1869027 R92109195 RUI SMQ_TERM_LMVERSION 8.1 Angioedema (SMQ)
C1869037 R92110670 RUI SMQ_TERM_LMVERSION 8.1 Peripheral neuropathy (SMQ)
C1869039 R92111002 RUI SMQ_TERM_LMVERSION 9.0 Depression and suicide/self-injury (SMQ)
C0338908 R92079872 RUI SMQ_TERM_LMVERSION 9.0 Mixed anxiety & depressive
SMQ_TERM_SCOPE  (return to top)
cui metaui stype atn atv str
C0232815 R92087417 RUI SMQ_TERM_SCOPE 1 Renal clearances low
C1869008 R92105447 RUI SMQ_TERM_SCOPE 1 Acute renal failure (SMQ)
C0860948 R92092744 RUI SMQ_TERM_SCOPE 1 Urea renal clearance abnormal
C1869091 R92105830 RUI SMQ_TERM_SCOPE 1 Cardiac failure (SMQ)
C0877269 R92094630 RUI SMQ_TERM_SCOPE 1 Hepatic induced oedema
C1869019 R92106784 RUI SMQ_TERM_SCOPE 1 Possible liver-related coagulation and bleeding disturbances (SMQ)
C1869023 R92107078 RUI SMQ_TERM_SCOPE 2 Haemolytic disorders (SMQ)
C1869024 R92107278 RUI SMQ_TERM_SCOPE 1 Severe cutaneous adverse reactions (SMQ)
C1187006 R92080172 RUI SMQ_TERM_SCOPE 1 Mucosal bulla
SMQ_TERM_STATUS  (return to top)
cui metaui stype atn atv str
C0085612 R92093154 RUI SMQ_TERM_STATUS A Ventricular arrhythmia NOS
C1869008 R92105370 RUI SMQ_TERM_STATUS A Acute renal failure (SMQ)
C0858792 R92071414 RUI SMQ_TERM_STATUS A Fingers swollen feeling of
C0438717 R92097325 RUI SMQ_TERM_STATUS A Transaminases increased
C0020433 R92062879 RUI SMQ_TERM_STATUS A Bilirubinaemia
C0542019 R92073976 RUI SMQ_TERM_STATUS A Hepatitis necrotizing
C0153080 R92093258 RUI SMQ_TERM_STATUS A Viral hepatitis B without mention of hepatic coma, without mention of hepatitis delta
C1869020 R92106907 RUI SMQ_TERM_STATUS A Liver infections (SMQ)
C1869023 R92107076 RUI SMQ_TERM_STATUS A Haemolytic disorders (SMQ)
SMQ_TERM_WEIGHT  (return to top)
cui metaui stype atn atv str
C0341677 R92068942 RUI SMQ_TERM_WEIGHT 0 Disorders resulting from impaired renal function
C1869020 R92106958 RUI SMQ_TERM_WEIGHT 0 Liver infections (SMQ)
C1869023 R92107002 RUI SMQ_TERM_WEIGHT 0 Haemolytic disorders (SMQ)
C0475858 R92086528 RUI SMQ_TERM_WEIGHT 0 Pruritus generalized
C1869038 R92107890 RUI SMQ_TERM_WEIGHT 0 Anaphylactic reaction (SMQ)
C1869038 R92108182 RUI SMQ_TERM_WEIGHT 0 Anaphylactic reaction (SMQ)
C0020517 R92087102 RUI SMQ_TERM_WEIGHT 0 Reaction allergic (NOS)
C1869027 R92109254 RUI SMQ_TERM_WEIGHT 0 Angioedema (SMQ)
C1869028 R92109393 RUI SMQ_TERM_WEIGHT 0 Asthma/bronchospasm (SMQ)
MXR  (return to top)
cui metaui lui sui stype code atn atv str
C0235885 A0928355 L0299189 S0870084 AUI 10014757 MXR WHOART: 1000001 Endometrial hypoplasia
C0024225 A0081561 L0024225 S0058704 AUI 10025226 MXR HARTS: 3270 Lymphangitis
C0221738 A1606865 L0313512 S1645190 AUI 10029719 MXR COSTART: REACT UNEVAL Nonspecific reaction
C0221731 A1595212 L0296376 S1635168 AUI 10034643 MXR COSTART: LIVER DAMAGE Periportal sinus dilatation
C0235802 A1603021 L0307773 S1641951 AUI 10037532 MXR WHOART: 0852001 Pupillary reflex impaired
C0035854 A0113112 L0035854 S0083311 AUI 10039218 MXR COSTART: ACNE Rosacea
C0236046 A1603420 L0308025 S1642270 AUI 10043818 MXR COSTART: HYPERTHYR Thyroxine increased
C0007286 A0399509 L0007286 S0362449 AUI 10007697 MXR WHOART: 1397001 Carpal tunnel syndrome
C0020490 A0070795 L0020486 S0050416 AUI 10020675 MXR ICD9CM: 367.0 Hypermetropia
SMQ_TERM_LEVEL  (return to top)
cui metaui lui sui stype code atn atv str
C0476403 A1574454 L1366737 S1617617 CODE 10014431 SMQ_TERM_LEVEL 4 Electromyogram abnormal
C1720775 A1604611 L0161676 S1643298 CODE 10028880 SMQ_TERM_LEVEL 5 Necrosis tubular kidney
C1699181 A9460897 L5866277 S6723522 CODE 10065794 SMQ_TERM_LEVEL 5 Muscle weakness right-sided
C1736185 A10926865 L6108323 S7015985 CODE 10066737 SMQ_TERM_LEVEL 5 Subacute pulmonary oedema
C0151849 A1578454 L1030404 S1620940 CODE 10001771 SMQ_TERM_LEVEL 5 ALP increased
C0856724 A1583565 L1371613 S1625263 CODE 10045478 SMQ_TERM_LEVEL 5 Unconjugated bilirubinaemia
C0022346 A2849410 L0022346 S0054807 CODE 10023126 SMQ_TERM_LEVEL 4 Jaundice
C0019158 A1601780 L0161588 S1640914 CODE 10019789 SMQ_TERM_LEVEL 5 Hepatitis nonspecific
C0854795 A1605228 L1382466 S1643827 CODE 10025626 SMQ_TERM_LEVEL 5 Malignant liver tumor resectable
MPS  (return to top)
cui metaui lui sui stype code atn atv str
C0274702 A0895646 L0161432 S0837193 SDUI 10008674 MPS 10029205 Cholinergic syndrome
C0018924 A0712663 L0018924 S0657677 SDUI 10018829 MPS 10028395 Haemarthrosis
C0151775 A0970516 L0161654 S0913865 SDUI 10022081 MPS 10018065 Injection site mass
C0264268 A1606490 L0313000 S1644870 SDUI 10028766 MPS 10038738 Nasal septum ulceration
C0015967 A0108244 L0034247 S0078979 SDUI 10037660 MPS 10018065 Pyrexia
C0035345 A0111763 L0035345 S0082320 SDUI 10038942 MPS 10041244 Retirement
C0337364 A1598271 L0569870 S1637920 SDUI 10030174 MPS 10042613 Oesophageal lesion excision
C0152243 A0265573 L0178867 S0243368 SDUI 10017590 MPS 10038604 Galactocele
C0008058 A1590542 L1375447 S1631156 SDUI 10008528 MPS 10022117 Chillblains
SMQ_ALGO  (return to top)
cui metaui lui sui stype code atn atv str
C1869006 A12057156 L6511616 S7585752 SDUI 20000001 SMQ_ALGO N Torsade de pointes/QT prolongation (SMQ)
C1869007 A12057867 L6511681 S7585665 SDUI 20000002 SMQ_ALGO N Rhabdomyolysis/myopathy (SMQ)
C1869008 A12056800 L6511448 S7585289 SDUI 20000003 SMQ_ALGO N Acute renal failure (SMQ)
C1869091 A12057875 L6511505 S7585241 SDUI 20000004 SMQ_ALGO N Cardiac failure (SMQ)
C1869009 A12057733 L6511462 S7585426 SDUI 20000005 SMQ_ALGO N Hepatic disorders (SMQ)
C1869010 A12057517 L6511484 S7585620 SDUI 20000006 SMQ_ALGO N Possible drug related hepatic disorders - comprehensive search (SMQ)
C1869011 A12056801 L6511901 S7585621 SDUI 20000007 SMQ_ALGO N Possible drug related hepatic disorders - severe events only (SMQ)
C1869012 A12057868 L6511726 S7585510 SDUI 20000008 SMQ_ALGO N Liver related investigations, signs and symptoms (SMQ)
C1869014 A12057518 L6511652 S7585428 SDUI 20000010 SMQ_ALGO N Hepatitis, non-infectious (SMQ)
SMQ_LEVEL  (return to top)
cui metaui lui sui stype code atn atv str
C1869006 A12057156 L6511616 S7585752 SDUI 20000001 SMQ_LEVEL 1 Torsade de pointes/QT prolongation (SMQ)
C1869007 A12057867 L6511681 S7585665 SDUI 20000002 SMQ_LEVEL 1 Rhabdomyolysis/myopathy (SMQ)
C1869008 A12056800 L6511448 S7585289 SDUI 20000003 SMQ_LEVEL 1 Acute renal failure (SMQ)
C1869091 A12057875 L6511505 S7585241 SDUI 20000004 SMQ_LEVEL 1 Cardiac failure (SMQ)
C1869010 A12057517 L6511484 S7585620 SDUI 20000006 SMQ_LEVEL 2 Possible drug related hepatic disorders - comprehensive search (SMQ)
C1869011 A12056801 L6511901 S7585621 SDUI 20000007 SMQ_LEVEL 3 Possible drug related hepatic disorders - severe events only (SMQ)
C1869013 A12056802 L6511443 S7585261 SDUI 20000009 SMQ_LEVEL 3 Cholestasis and jaundice of hepatic origin (SMQ)
C1869015 A12056621 L6511665 S7585509 SDUI 20000011 SMQ_LEVEL 4 Liver neoplasms, malignant and unspecified (SMQ)
C1869016 A12057869 L6511664 S7585508 SDUI 20000012 SMQ_LEVEL 4 Liver neoplasms, benign (SMQ)
SMQ_STATUS  (return to top)
cui metaui lui sui stype code atn atv str
C1869006 A12057156 L6511616 S7585752 SDUI 20000001 SMQ_STATUS A Torsade de pointes/QT prolongation (SMQ)
C1869007 A12057867 L6511681 S7585665 SDUI 20000002 SMQ_STATUS A Rhabdomyolysis/myopathy (SMQ)
C1869008 A12056800 L6511448 S7585289 SDUI 20000003 SMQ_STATUS A Acute renal failure (SMQ)
C1869091 A12057875 L6511505 S7585241 SDUI 20000004 SMQ_STATUS A Cardiac failure (SMQ)
C1869009 A12057733 L6511462 S7585426 SDUI 20000005 SMQ_STATUS A Hepatic disorders (SMQ)
C1869010 A12057517 L6511484 S7585620 SDUI 20000006 SMQ_STATUS A Possible drug related hepatic disorders - comprehensive search (SMQ)
C1869011 A12056801 L6511901 S7585621 SDUI 20000007 SMQ_STATUS A Possible drug related hepatic disorders - severe events only (SMQ)
C1869012 A12057868 L6511726 S7585510 SDUI 20000008 SMQ_STATUS A Liver related investigations, signs and symptoms (SMQ)
C1869014 A12057518 L6511652 S7585428 SDUI 20000010 SMQ_STATUS A Hepatitis, non-infectious (SMQ)
SMQ_SOURCE  (return to top)
cui metaui lui sui stype code atn atv str
C1869006 A12057156 L6511616 S7585752 SDUI 20000001 SMQ_SOURCE Zipes DP. Specific arrhythmias: diagnosis and treatment. Heart Disease: A Textbook of Cardiovascular Medicine (5th Ed). Braunwald E (Ed). WB Saunders: Philadelphia, 1997, pg. 640-704. Marriott HJL and Conover MB. Polymorphic ventricular tachycardia. Advanced Concepts in Arrhythmias (3rd Ed). Mosby: New York, 1998, pg. 293-310. Definitions and basic requirements for the use of terms for reporting adverse drug reactions (XI): cardiovascular system disorders. Pharmacoepidemiology and Drug Safety 1998; 7:351-357. Torsade de pointes. Reporting Adverse Drug Reactions: Definitions of Terms and Criteria for Their Use. Bankowski Z, Bruppacher R, Crusius I et al (Eds). Council for International Organizations of Medical Sciences: Geneva, 1999, pg. 81-82 Josephson ME and Zimetbaum P. The tachyarrhythmias. Harrison's Principles of Internal Medicine (15th Ed). Braunwald E, Fauci AS, Kasper DL et al (Eds). McGraw-Hill: New York, 2001, pg. 1292-1309. Bauman JL and Schoen MD. Arrhythmias. Pharmacotherapy: A Pathophysiologic Approach (5th Ed). DiPiro JT, Talbert RL, Yee GC et al (Eds). McGraw-Hill: New York, 2002, pg. 273-303. Torsade de pointes/QT prolongation (SMQ)
C1869007 A12057867 L6511681 S7585665 SDUI 20000002 SMQ_SOURCE Basic requirements for the use of terms for reporting adverse drug reactions (IV). Pharmacoepidemiology and Drug Safety 1993; 2:149-153. Myopathy. Reporting Adverse Drug Reactions: Definitions of Terms and Criteria for Their Use. Bankowski Z, Bruppacher R, Crusius I et al (Eds). Council for International Organizations of Medical Sciences: Geneva, 1999, pg. 16-17. Poels PJE and Gabreels FJM. Rhabdomyolysis: a review of the literature. Clin Neurol Neurosurg 1993; 95:175-192. Omar MA, Wilson JP, and Cox, TS. Rhabdomyolysis and HMG-CoA reductase inhibitors. Annals Pharmacother 2001; 35:1096-1107. Prendergast BD and George CF. Drug-induced rhabdomyolysis - mechanisms and management. Postgrad Med J 1993; 69:333-336. Rhabdomyolysis/myopathy (SMQ)
C1869008 A12056800 L6511448 S7585289 SDUI 20000003 SMQ_SOURCE The Merck Manual, 17th Edition Cecil Textbook of Medicine, 19th Edition Harrison's Principles of Internal Medicine, 13th Edition Acute renal failure (SMQ)
C1869091 A12057875 L6511505 S7585241 SDUI 20000004 SMQ_SOURCE Council for International Organisations of Medical Sciences (CIOMS). Reporting Adverse Drug Reactions. Definition of terms and criteria for their use. 1999: p 64-65 Cardiac failure (SMQ)
C1869024 A12057520 L6511492 S7585682 SDUI 20000020 SMQ_SOURCE Roujeau JC and Stern RS. Severe adverse cutaneous reactions to drugs. New England Journal of Medicine 1994; 331: 1272-1285. Reporting Adverse Drug Reactions. Definitions of terms and criteria for their use. CIOMS publication, Geneva 1999. Severe cutaneous adverse reactions (SMQ)
C1869038 A12057161 L6511588 S7585462 SDUI 20000021 SMQ_SOURCE 1 The Merck Manual. 15th edition. Merck, Sharp & Dohme Research Laboratories. (1987): 306-7 Anaphylactic reaction (SMQ)
C1869025 A12057005 L6511764 S7585273 SDUI 20000022 SMQ_SOURCE 1. Anonymous. Pancreatitis. Reporting Adverse Drug Reactions: Definitions of Terms and Criteria for Their Use. Bankowski Z, Bruppacher R, Crusius I et al (Eds). Council for International Organizations of Medical Sciences: Geneva, 1999, pp 53-54 2. Berardi RR and Montgomery PA. Pancreatitis. Pharmacotherapy: A Pathophysiologic Approach (5th Ed). DiPiro JT, Talbert RL, Yee GC et al (Eds). McGraw-Hill: New York, NY. 1999. pp 701-715 3. Greenberger NJ, Toskes PP, and Isselbacher KJ. Acute and chronic pancreatitis. Harrison's Principles of Internal Medicine (14th Ed). Fauci AS, Braunwald E, Isselbacher KJ et al (Eds). McGraw-Hill: New York, NY. 1998. pp 1741-1752 Acute pancreatitis (SMQ)
C1869026 A12056983 L6511876 S7585355 SDUI 20000023 SMQ_SOURCE 1. Reporting Adverse Drug Reactions, Definitions and Criteria for Their Use, CIOMS, Geneva, 1999 2. Harrison's Principles of Internal Medicine, 15th edition, Eugene Braunwald [et al.], McGraw-Hill, 2001 Agranulocytosis (SMQ)
C1869027 A12056622 L6511474 S7585499 SDUI 20000024 SMQ_SOURCE 1. Bankowski Z, Bruppacher R, Crusius I et al. Reporting adverse drug reactions, definition of terms and criteria for their use. Council for International Organizations of Medical Sciences (CIOMS) 1999 pp 12 -13 2. Dorland's Illustrated Medical Dictionary, 28th Edition 1994 p78 3. Braunwald E, Fauci A and Kasper D. Harrison's Principles of Internal Medicine, 15th Edition, 2001 p 341 and pp 1917-1918 4. Beers M and Berkow R. The Merck Manual of diagnosis and therapy, 17th edition, dated 1999 pp 1054-56 Angioedema (SMQ)
SOS  (return to top)
cui metaui lui sui stype code atn atv str
C1869006 A12057156 L6511616 S7585752 SDUI 20000001 SOS 1. Includes sudden and cardiac death terms as this is a frequent association with torsade de pointes. Torsade de pointes/QT prolongation (SMQ)
C1869007 A12057867 L6511681 S7585665 SDUI 20000002 SOS 1. Renal impairment/failure terms included because of the frequent association with rhabdomyolysis Rhabdomyolysis/myopathy (SMQ)
C1869091 A12057875 L6511505 S7585241 SDUI 20000004 SOS The CIOMS Working Group discussed in detail whether an algorithm could be applied to this SMQ based on the definition of cardiac failure provided. Such an algorithm, however, has not been tested by the CIOMS Working Group, therefore, the Working Group is requesting users to comment on the practical relevance of an algorithm approach. Such an algorithm could involve broad tersmsas follows: one oedema term, one dyspnoea term plus one clinical/sign/symptom or investigation making up 3 terms in total Cardiac failure (SMQ)
C1869038 A12057161 L6511588 S7585462 SDUI 20000021 SOS The following algorithm is used: All narrow search terms as well as: If one term from category B and one term from category C is present, or If one term from (category B or category C) plus one term from category D. Anaphylactic reaction (SMQ)
C1869025 A12057005 L6511764 S7585273 SDUI 20000022 SOS To apply algorithm - A report is considered a relevant case for further review if: 1) it includes a term from Category A (Narrow terms) OR 2) it includes at least one term from Category B (the list of laboratory values) and at least one term from Category C (the list of signs and symptoms) Acute pancreatitis (SMQ)
C1869026 A12056983 L6511876 S7585355 SDUI 20000023 SOS If possible, full blood counts and repeated white blood cell counts should be reported, sought for in follow up, and coded. Concerning database queries with broad search terms, additionally coded data on hematological values help to find relevant cases more easily. In case laboratory values are not coded in a database, individual review is then needed to decide upon relevance in the context of agranulocytosis. Agranulocytosis (SMQ)
C1869030 A12057521 L6511580 S7585405 SDUI 20000027 SOS Cases with no link to the category "Cytopenia and haematopoietic disorders affecting more than one type of blood cells" need to be reviewed for combinations of AEs/ADRs assigned to at least two of the other three SMQs to find all such cases. All types of potential combinations appear possible and need to be considered. Haematopoietic cytopenias (SMQ)
C1869031 A12056805 L6511767 S7585299 SDUI 20000028 SOS Cases with no link to the category "Cytopenia and haematopoietic disorders affecting more than one type of blood cells" need to be reviewed for combinations of AEs/ADRs assigned to at least two of the other three SMQs to find all such cases. All types of potential combinations appear possible and need to be considered. Cytopenia and haematopoietic disorders affecting more than one type of blood cell (SMQ)
C1869032 A12057344 L6511573 S7585354 SDUI 20000029 SOS Cases with no link to the category "Cytopenia and haematopoietic disorders affecting more than one type of blood cells" need to be reviewed for combinations of AEs/ADRs assigned to at least two of the other three SMQs to find all such cases. All types of potential combinations appear possible and need to be considered. Erythropenia (SMQ)
MISO  (return to top)
cui metaui lui sui stype code atn atv str
C1261322 A0976668 L0861064 S0919672 SDUI 10022891 MISO 23 Investigations
C0018799 A1588768 L0537218 S1629626 SDUI 10007541 MISO 11 Cardiac disorders
C0851352 A2016522 L1376503 S2162599 SDUI 10010331 MISO 21 Congenital, familial and genetic disorders
C0851353 A1585002 L1372278 S1626383 SDUI 10005329 MISO 03 Blood and lymphatic system disorders
C0027765 A1596081 L0297185 S1635977 SDUI 10029205 MISO 08 Nervous system disorders
C0015397 A1595746 L0012705 S1635657 SDUI 10015919 MISO 09 Eye disorders
C0851354 A1595679 L1378038 S1635566 SDUI 10013993 MISO 10 Ear and labyrinth disorders
C0851355 A1595973 L1378186 S1635875 SDUI 10038738 MISO 13 Respiratory, thoracic and mediastinal disorders
C0017178 A1595807 L0161543 S1635716 SDUI 10017947 MISO 14 Gastrointestinal disorders
FROMRSAB  (return to top)
cui metaui lui sui stype code atn atv str
C2242749 A14225251 L7591868 S8789399 CODE MTHU000002 FROMRSAB MDR MDR11_0 to ICD9CM_1998 Mappings
C2242750 A14224944 L7591910 S8789398 CODE MTHU000001 FROMRSAB MDR MDR11_0 to CST95 Mappings
FROMVSAB  (return to top)
cui metaui lui sui stype code atn atv str
C2242749 A14225251 L7591868 S8789399 CODE MTHU000002 FROMVSAB MDR11_0 MDR11_0 to ICD9CM_1998 Mappings
C2242750 A14224944 L7591910 S8789398 CODE MTHU000001 FROMVSAB MDR11_0 MDR11_0 to CST95 Mappings
MAPSETRSAB  (return to top)
cui metaui lui sui stype code atn atv str
C2242749 A14225251 L7591868 S8789399 CODE MTHU000002 MAPSETRSAB MDR MDR11_0 to ICD9CM_1998 Mappings
C2242750 A14224944 L7591910 S8789398 CODE MTHU000001 MAPSETRSAB MDR MDR11_0 to CST95 Mappings
MAPSETTYPE  (return to top)
cui metaui lui sui stype code atn atv str
C2242749 A14225251 L7591868 S8789399 CODE MTHU000002 MAPSETTYPE MedDRA to ICD9CM Mappings MDR11_0 to ICD9CM_1998 Mappings
C2242750 A14224944 L7591910 S8789398 CODE MTHU000001 MAPSETTYPE MedDRA to COSTART Mappings MDR11_0 to CST95 Mappings
MAPSETVERSION  (return to top)
cui metaui lui sui stype code atn atv str
C2242749 A14225251 L7591868 S8789399 CODE MTHU000002 MAPSETVERSION 200803 MDR11_0 to ICD9CM_1998 Mappings
C2242750 A14224944 L7591910 S8789398 CODE MTHU000001 MAPSETVERSION 200803 MDR11_0 to CST95 Mappings
MAPSETVSAB  (return to top)
cui metaui lui sui stype code atn atv str
C2242749 A14225251 L7591868 S8789399 CODE MTHU000002 MAPSETVSAB MDR11_0 MDR11_0 to ICD9CM_1998 Mappings
C2242750 A14224944 L7591910 S8789398 CODE MTHU000001 MAPSETVSAB MDR11_0 MDR11_0 to CST95 Mappings
MTH_MAPFROMCOMPLEXITY  (return to top)
cui metaui lui sui stype code atn atv str
C2242749 A14225251 L7591868 S8789399 CODE MTHU000002 MTH_MAPFROMCOMPLEXITY SINGLE CODE MDR11_0 to ICD9CM_1998 Mappings
C2242750 A14224944 L7591910 S8789398 CODE MTHU000001 MTH_MAPFROMCOMPLEXITY SINGLE CODE MDR11_0 to CST95 Mappings
MTH_MAPFROMEXHAUSTIVE  (return to top)
cui metaui lui sui stype code atn atv str
C2242749 A14225251 L7591868 S8789399 CODE MTHU000002 MTH_MAPFROMEXHAUSTIVE N MDR11_0 to ICD9CM_1998 Mappings
C2242750 A14224944 L7591910 S8789398 CODE MTHU000001 MTH_MAPFROMEXHAUSTIVE N MDR11_0 to CST95 Mappings
MTH_MAPSETCOMPLEXITY  (return to top)
cui metaui lui sui stype code atn atv str
C2242749 A14225251 L7591868 S8789399 CODE MTHU000002 MTH_MAPSETCOMPLEXITY ONE_TO_ONE MDR11_0 to ICD9CM_1998 Mappings
C2242750 A14224944 L7591910 S8789398 CODE MTHU000001 MTH_MAPSETCOMPLEXITY ONE_TO_ONE MDR11_0 to CST95 Mappings
MTH_MAPTOCOMPLEXITY  (return to top)
cui metaui lui sui stype code atn atv str
C2242749 A14225251 L7591868 S8789399 CODE MTHU000002 MTH_MAPTOCOMPLEXITY SINGLE CODE MDR11_0 to ICD9CM_1998 Mappings
C2242750 A14224944 L7591910 S8789398 CODE MTHU000001 MTH_MAPTOCOMPLEXITY SINGLE CODE MDR11_0 to CST95 Mappings
MTH_MAPTOEXHAUSTIVE  (return to top)
cui metaui lui sui stype code atn atv str
C2242749 A14225251 L7591868 S8789399 CODE MTHU000002 MTH_MAPTOEXHAUSTIVE N MDR11_0 to ICD9CM_1998 Mappings
C2242750 A14224944 L7591910 S8789398 CODE MTHU000001 MTH_MAPTOEXHAUSTIVE N MDR11_0 to CST95 Mappings
TORSAB  (return to top)
cui metaui lui sui stype code atn atv str
C2242749 A14225251 L7591868 S8789399 CODE MTHU000002 TORSAB ICD9CM MDR11_0 to ICD9CM_1998 Mappings
C2242750 A14224944 L7591910 S8789398 CODE MTHU000001 TORSAB CST MDR11_0 to CST95 Mappings
TOVSAB  (return to top)
cui metaui lui sui stype code atn atv str
C2242749 A14225251 L7591868 S8789399 CODE MTHU000002 TOVSAB ICD9CM_1998 MDR11_0 to ICD9CM_1998 Mappings
C2242750 A14224944 L7591910 S8789398 CODE MTHU000001 TOVSAB CST95 MDR11_0 to CST95 Mappings

Last reviewed: 09 January 2009
Last updated: 09 January 2009
First published: 23 December 2008
Metadata| Permanence level: Permanence Not Guaranteed